For the gene polymorphism, a series of studies showed that RA patients carrying TNF-α rs1800629 -GG genotype were better responders to infliximab, while the presence of A allele significantly decreases the response to infliximab (130–133). This evidence concerns the gene TNF and rheumatoid arthritis.